mbeck

Canada’s health security requires increased research support: Op-Ed by NMIN researchers

“Canada’s biomedical community can clearly be competitive globally. However, we need investment in research and development, as well as infrastructure, to enable end-to-end, made-in-Canada solutions that can help Canadians and ensure health security.” This is the key message of an opinion piece by NMIN research leaders Drs. Pieter Cullis and… Read More »Canada’s health security requires increased research support: Op-Ed by NMIN researchers

NMIN Researchers Drs. Christine Allen & Pieter Cullis receive Controlled Release Society awards

Two NMIN researchers were recently recognized with awards from the Controlled Release Society (CRS). Dr. Christine Allen was awarded the CRS 2021 Women in Science award acknowledging her international recognition for outstanding contributions in science and technology. Dr. Pieter Cullis was awarded the 2021 CRS Founders Award, acknowledging his international… Read More »NMIN Researchers Drs. Christine Allen & Pieter Cullis receive Controlled Release Society awards

NMIN researcher’s company develops new DNA-based COVID-19 vaccine

Edmonton-based company Entos Pharmaceuticals has developed a new DNA-based vaccine for COVID-19 that is expected to enter Phase 1 clinical trials soon. NMIN researcher Dr. John Lewis, associate professor of oncology at the University of Alberta, is CEO of Entos. At the outset of the pandemic, the company repurposed its… Read More »NMIN researcher’s company develops new DNA-based COVID-19 vaccine

NMIN’s Scientific Director changes course

Dr. Cullis stepping down as Scientific Director to pursue commercialization opportunities NMIN’s founding Scientific Director, Dr. Pieter Cullis, seizes yet another new opportunity. Over his celebrated career, he has spearheaded numerous innovations and created a range of new business opportunities for Canadians through his intrepid entrepreneurialism. Most recently, his aptitude… Read More »NMIN’s Scientific Director changes course

NMIN’s Scientific Director tells the story of the LNP delivery system behind Pfizer’s COVID-19 vaccine

In a January 15, 2021 seminar organized by the Life Sciences Institute of the University of British Columbia, NMIN’s Scientific Director Dr. Pieter Cullis shared a first-hand account of the 40-year scientific journey that culminated in the lipid nanoparticle (LNP) delivery system underpinning the Pfizer/BioNTech vaccine against COVID-19. Watch the… Read More »NMIN’s Scientific Director tells the story of the LNP delivery system behind Pfizer’s COVID-19 vaccine

Nano versus Molecular: Optical Imaging Approaches to Detect and Monitor Tumor Hypoxia – a review by NMIN researcher & trainees

In a review article published today in Advanced Healthcare Materials, NMIN trainees Dr. Miffy Hok Yan Cheng and Yulin Mo, together with NMIN researcher Dr. Gang Zheng, survey the latest nano and molecular developments in optical imaging approaches for detecting and monitoring hypoxia in solid tumours. “Hypoxia is a hallmark… Read More »Nano versus Molecular: Optical Imaging Approaches to Detect and Monitor Tumor Hypoxia – a review by NMIN researcher & trainees

NMIN researchers featured in 30th anniversary issues of Bioconjugate Chemistry

Three reviews by NMIN researchers – Drs Pieter Cullis, Shana Kelley, Dominik Witzigmann, and Gang Zheng – have been honoured with inclusion in 30th anniversary issues of the journal Bioconjugate Chemistry. “Throughout 2020, Bioconjugate Chemistry is holding a year-round celebration with a special group of invited review authors,” comments NMIN… Read More »NMIN researchers featured in 30th anniversary issues of Bioconjugate Chemistry

Canadian technology enables Pfizer’s COVID-19 vaccine

https://youtu.be/M-NUP8Xs9-g Above: watch the 26 April 2021 coverage of this story by GlobalNews. See also the CIHR’s timeline and video “The long road to mRNA vaccines,” featuring the contributions highlighted here. Pfizer caught the world’s attention with its promising early results for a COVID-19 vaccine candidate. What has been less… Read More »Canadian technology enables Pfizer’s COVID-19 vaccine

NMIN research on entrapment of siRNA within LNPs published in Nanoscale

A new article by NMIN researchers published in the journal Nanoscale sheds light on a potential mechanism by which lipid nanoparticle (LNP) formulations of nucleic acid encapsulate short interfering RNA (siRNA). “Genetic drugs based on RNA or DNA have a remarkable potential to treat virtually any disease,” comments NMIN Scientific… Read More »NMIN research on entrapment of siRNA within LNPs published in Nanoscale